Oncology Biosimilar Market by Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, and Others), By Drug Type (mAb, Immunomodulators, Hematopoietic Agents, G-CSF, and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Global oncology biosimilar market expected to generate revenue of around USD 13,993.64 million by end of 2024, growing at a CAGR of around 26.8% between 2018 and 2024. Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer.

12-Jul-2018 | Number of pages: 110 | Report Code: ZMR-3228 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the oncology biosimilar market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based revenue (USD Million). The study includes drivers and restraints for the oncology biosimilar market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the oncology biosimilar market on a global level.

In order to give the users of this report a comprehensive view on the oncology biosimilar market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, where test type, drug type, distribution channel and regional segmentation are benchmarked based on their market size, growth rate, and general attractiveness.

Global Oncology Biosimilar Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new test type launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved on the market on the global and regional basis.

The study provides a decisive view on the oncology biosimilar market by segmenting the market based on test type, drug type, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market are estimated from 2018 to 2024. 

Based on test type, the oncology biosimilar market is segmented as breast cancer, colorectal cancer, blood cancer, neutropenia cancer, non-small cell lung cancer and others. Based on the distribution channel, the oncology biosimilar market is segmented as retail pharmacies, hospital pharmacy, and online pharmacy. 

Increasing demand for affordable therapies due to the constant increase in cancer patients is one of the major driving factors of oncology biosimilar market. High medical expenses associated with cancer treatment; the lack of awareness and dearth of skilled personnel are factors that influence the market growth during the forecast period.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries, including the U.S., Canada, Mexico, Germany, Spain, Italy, France, UK, China, Japan, India, and Brazil. This segment includes demand for oncology biosimilar market based on individual segment and test types in all the regions and countries.

The report also includes detailed profiles of end players such as Teva Pharmaceutical Industries Ltd., Biocon, STADA Arzneimittel AG, Sandoz International GmbH, Intas Pharmaceuticals Ltd., Celltrion Inc., Pfizer Inc., Apotex Inc., Dr. Reddy’s Laboratories Ltd., and BIOCAD, among others. 

This report segments the global oncology biosimilar market as follows:

Global Oncology Biosimilar Market: by Test Type

  • Breast Cancer
  • Colorectal Cancer
  • Blood Cancer
  • Neutropenia Cancer
  • Non-Small Cell Lung Cancer
  • Others

Global Oncology Biosimilar Market: Drug Type Segment Analysis:

  • mAb
  • Immunomodulators
  • Hematopoietic Agents
  • G-CSF 
  • Others

Global Oncology Biosimilar Market: by Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacy
  • Online Pharmacy

Global Oncology Biosimilar Market: by Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Rheumatoid Arthritis Drugs Market by Drug Type (NSAID’s, Analgesics, DMARD’s, Glucocorticoids, Biologics, and Others) and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Sales): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Apr-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3999 | Report Format:

The report covers a forecast and an analysis of the rheumatoid arthritis drugs market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the rheuma...Read More

Pharmaceutical Vials Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3985 | Report Format:

Global Pharmaceutical Vials Market: Overview Pharmaceutical vials are a type of small containers that are used for the purpose of storing liquid medications. They are made up of plastic or glass and are mainly used for unit dose packaging of medications. Pharmaceutical vials also help patients i...Read More

Immuno Oncology Assays Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3963 | Report Format:

Global Immuno Oncology Assays Market: Overview Immuno Oncology Assays are used when testing immunotherapies as it is often critical to assess thefunctional cytotoxicity and infiltration capacity. In addition, Immunomodulators effects of these new drugs in combination with already approved ones n...Read More

Drug Integrated Polymer Fibers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3933 | Report Format:

Global Drug Integrated Polymer Fibers Market: Overview Drug integrated polymers fibers are generally made from biodegradable and biocompatible materials such as poly lactic acid and its derivatives such as PLLA, polydioxanone, polycaprolactone, polyglycolic acid, poly(lactic-co-glycolic acid), a...Read More

Gynecological Drugs Market by Therapeutics (Hormonal Therapy and Non-Hormonal Therapy), by Indication (Gynecology Cancers, Endometriosis, Female Infertility, Menopausal Disorder, Gynecology Infections, Polycystic Ovary Syndrome, Contraception (Birth Control), and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Mar-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3926 | Report Format:

The report covers a forecast and an analysis of the gynecological drugs market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the gyneco...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.